“…Risk factors identified from studies of patients with acute lymphoblastic leukemia and brain tumors include young age at treatment [13,23,3,1], dose and type of treatment, particularly cranial irradiation and high-dose chemotherapy [13,15,25], increased time since treatment [26,23], and female gender [3]. Structural changes, including subacute leukoencephalopathy, mineralizing microangiopathy, and cortical atrophy, have been observed on CT or MRI during and after treatment [5], but associations between NP deficits and structural abnormalities are inconsistent and yield mixed results [18,28]. Early detection and improved objective characterization of NT would be useful in the clinical management of these patients.…”